DALLAS (AP) _ Abeona Therapeutics Inc. (ABEO) on Friday reported a loss of $18.6 million in its first quarter.
The Dallas-based company said it had a loss of 39 cents per share.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.
Abeona Therapeutics shares have risen nearly 8% since the beginning of the year. In the final minutes of trading on Friday, shares hit $7.68, a decrease of 59% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABEO at https://www.zacks.com/ap/ABEO